Related Experiment Video

Updated: Jun 23, 2026

Accurate and Simple Evaluation of Vascular Anastomoses in Monochorionic Placenta using Colored Dye
09:52

Accurate and Simple Evaluation of Vascular Anastomoses in Monochorionic Placenta using Colored Dye

Published on: September 5, 2011

[Fetal and neonatal alloimmune thrombocytopenias]

C Kaplan1

  • 1Immunologie Plaquettaire, Institut National de la Transfusion Sanguine, 75739 Paris cedex 15, France. ckaplan@ints.fr

Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine
|May 5, 2009
PubMed

Insights

Fetal and neonatal alloimmune thrombocytopenias (FNAIT) occur when mothers develop antibodies against fetal platelets. Severe FNAIT can cause intracranial hemorrhage, but diagnosis and management have advanced significantly.

Area of Science:

  • Immunology
  • Hematology
  • Perinatology

Context:

  • Fetal and neonatal alloimmune thrombocytopenias (FNAIT) arise from maternal antibodies targeting fetal platelet antigens absent in the mother.
  • Affecting 1 in 800-1000 live births, FNAIT poses a risk of severe complications, notably intracranial hemorrhage.

Purpose:

  • To review the pathogenesis, diagnosis, and management of FNAIT.
  • To highlight diagnostic challenges and emphasize timely treatment initiation.

Summary:

  • FNAIT is caused by maternal immunization against paternal-origin fetal platelet-specific antigens.
  • Intracranial hemorrhage is the most severe complication, potentially leading to mortality or neurological deficits.
  • Diagnosis involves detecting maternal alloantibodies and identifying the specific antigen; prompt treatment is crucial despite diagnostic complexities.

Impact:

  • Advances in laboratory diagnostics and clinical management have improved outcomes for FNAIT.
  • Understanding FNAIT pathogenesis aids in developing targeted therapies and preventative strategies.
  • Improved diagnosis and management reduce the risk of severe fetal and neonatal complications.

More Related Videos

Isolation of Leukocytes from the Murine Tissues at the Maternal-Fetal Interface07:51

Isolation of Leukocytes from the Murine Tissues at the Maternal-Fetal Interface

Published on: May 21, 2015

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Rh Blood Group01:19

Rh Blood Group

The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.